ATP6V0D1 and COVID-19: The expressions of pro-viral ATP6V0D1 and DPAGT1 and anti-viral DAZAP2 were upregulated, whereas no difference in the expression was observed for pro-viral VTA1, in severe COVID-19 patients (Supplementary Fig. 5).